ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

DTIL vs IVVD // NET PROFIT MARGIN

Precision BioSciences Inc. (NASDAQ) VS. Invivyd Inc. (NASDAQ) • 15-METRIC TALLY: DTIL 2 — IVVD 2
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (DTIL VS. IVVD) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC DTIL IVVD SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin ACTIVE -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) -50.10% 110.50% -160.60 IVVD /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.20 0.20 0.00 TIE /balance-sheet <GO>
Piotroski F-Score Quality 1/9 3/9 -2.00 IVVD /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 55.8 36.2 +19.60 DTIL /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $205.4M $177.4M $27.9M DTIL /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR DTIL REV IVVD REV DTIL GROSS % IVVD GROSS % DTIL FCF IVVD FCF
FY 2025 $34.3M $53.4M — — -$65.8M -$58.3M
FY 2024 $68.7M $25.4M — — -$58.4M -$170.6M
FY 2023 $48.7M $0 — — -$84.1M -$173.2M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
DTIL // BETA —
IVVD // BETA —